Medison Pharma and Partners Healthcare could be in line for exits after the haematological and musculoskeletal disorder therapy developer filed to raise $86.3m.

Owlcam has been acquired by Xirgo Technologies for an undisclosed sum two years after emerging from stealth, having raised $28m from investors including CSAA.

Wipro Ventures exited email security software developer Emailage, when it was acquired by LexisNexis Risk Solutions. The sizeable deal is part of the wider cybersecurity space which has been popular over recent years.

Ping An-backed health services provider Fullerton could theoretically seek an acquisition deal or spin off its digital division.

Pfizer and Lundbeck scored exits as blood-disease therapy developer Imara raised $75.2m, floating at the foot of its range.

The genetic therapy developer, which had raised $126m in funding from investors including Eli Lilly and Access Industries, added $32.4m to the offering.

Underwriters have exercised their over-allotment option in full, increasing the University of Pennsylvania-linked genetic medicine developer’s proceeds by $32.4m.

The wages advance service has been acquired by working capital financing supplier Greensill after raising $2.5m from investors including NAB in early 2019.

Cemex Ventures has exited concrete analysis technology developer Concrete Sensors having participated in a $2.9m round less than two years ago.

Robert Bosch Venture Capital has exited Modcam after investing $600,000 in the computer vision sensor developer in 2015.